563 related articles for article (PubMed ID: 24568628)
1. Mapping the 25-item National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) to EQ-5D utility scores.
Kay S; Ferreira A
Ophthalmic Epidemiol; 2014 Apr; 21(2):66-78. PubMed ID: 24568628
[TBL] [Abstract][Full Text] [Related]
2. Reliability and validity of the National Eye Institute Visual Function Questionnaire-25 in patients with age-related macular degeneration.
Revicki DA; Rentz AM; Harnam N; Thomas VS; Lanzetta P
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):712-7. PubMed ID: 19797233
[TBL] [Abstract][Full Text] [Related]
3. Mapping the FACT-P to the preference-based EQ-5D questionnaire in metastatic castration-resistant prostate cancer.
Skaltsa K; Longworth L; Ivanescu C; Phung D; Holmstrom S
Value Health; 2014 Mar; 17(2):238-44. PubMed ID: 24636382
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of minimum clinically meaningful changes in scores on the National Eye Institute Visual Function Questionnaire (NEI-VFQ) SST Report Number 19.
Submacular Surgery Trials Research Group
Ophthalmic Epidemiol; 2007; 14(4):205-15. PubMed ID: 17896299
[TBL] [Abstract][Full Text] [Related]
5. Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degeneration.
Orr P; Rentz AM; Margolis MK; Revicki DA; Dolan CM; Colman S; Fine JT; Bressler NM
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3354-9. PubMed ID: 21282568
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the Relationship Between Visual Acuity and Utilities in Patients With Diabetic Macular Edema Enrolled in Intravitreal Aflibercept Studies.
Brazier J; Muston D; Konwea H; Power GS; Barzey V; Lloyd A; Sowade O; Vitti B; Gerlinger C; Roberts J
Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4818-4825. PubMed ID: 28973328
[TBL] [Abstract][Full Text] [Related]
7. Patient-reported visual function outcomes improve after ranibizumab treatment in patients with vision impairment due to diabetic macular edema: randomized clinical trial.
Mitchell P; Bressler N; Tolley K; Gallagher M; Petrillo J; Ferreira A; Wood R; Bandello F;
JAMA Ophthalmol; 2013 Oct; 131(10):1339-47. PubMed ID: 23974915
[TBL] [Abstract][Full Text] [Related]
8. Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration.
Cahill MT; Stinnett SS; Banks AD; Freedman SF; Toth CA
Ophthalmology; 2005 Jan; 112(1):144-51. PubMed ID: 15629835
[TBL] [Abstract][Full Text] [Related]
9. Cross-validation of the Turkish version of the 25-item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ 25).
Toprak AB; Eser E; Guler C; Baser FE; Mayali H
Ophthalmic Epidemiol; 2005 Aug; 12(4):259-69. PubMed ID: 16033747
[TBL] [Abstract][Full Text] [Related]
10. Baseline characteristics, the 25-Item National Eye Institute Visual Functioning Questionnaire, and their associations in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT).
Maguire M;
Ophthalmology; 2004 Jul; 111(7):1307-16. PubMed ID: 15234130
[TBL] [Abstract][Full Text] [Related]
11. Changes in vision- and health-related quality of life in patients with diabetic macular edema treated with pegaptanib sodium or sham.
Loftus JV; Sultan MB; Pleil AM;
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7498-505. PubMed ID: 21896838
[TBL] [Abstract][Full Text] [Related]
12. Mapping From Visual Acuity to EQ-5D, EQ-5D With Vision Bolt-On, and VFQ-UI in Patients With Macular Edema in the LEAVO Trial.
Pennington BM; Hernández-Alava M; Hykin P; Sivaprasad S; Flight L; Alshreef A; Brazier J
Value Health; 2020 Jul; 23(7):928-935. PubMed ID: 32762995
[TBL] [Abstract][Full Text] [Related]
13. Assessment of quality of life among Taiwanese patients with visual impairment.
Lin JC; Yu JH
J Formos Med Assoc; 2012 Oct; 111(10):572-9. PubMed ID: 23089693
[TBL] [Abstract][Full Text] [Related]
14. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
Hawton A; Green C; Telford C; Zajicek J; Wright D
Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
[TBL] [Abstract][Full Text] [Related]
15. Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trials.
Suñer IJ; Kokame GT; Yu E; Ward J; Dolan C; Bressler NM
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3629-35. PubMed ID: 19255158
[TBL] [Abstract][Full Text] [Related]
16. Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4.
Dong LM; Childs AL; Mangione CM; Bass EB; Bressler NM; Hawkins BS; Marsh MJ; Miskala P; Jaffee HA; McCaffrey LA;
Am J Ophthalmol; 2004 Jul; 138(1):91-108. PubMed ID: 15234287
[TBL] [Abstract][Full Text] [Related]
17. Psychometric performance of the National Eye Institute visual function questionnaire in Latinos and non-Latinos.
Baker RS; Bazargan M; Calderón JL; Hays RD
Ophthalmology; 2006 Aug; 113(8):1363-71. PubMed ID: 16877075
[TBL] [Abstract][Full Text] [Related]
18. Relative contributions of reduced vision and general health to NEI-VFQ scores in patients with neovascular age-related macular degeneration.
Miskala PH; Bressler NM; Meinert CL
Arch Ophthalmol; 2004 May; 122(5):758-66. PubMed ID: 15136325
[TBL] [Abstract][Full Text] [Related]
19. Effect of laser photocoagulation treatment for diabetic macular oedema on patient's vision-related quality of life.
Tranos PG; Topouzis F; Stangos NT; Dimitrakos S; Economidis P; Harris M; Coleman AL
Curr Eye Res; 2004 Jul; 29(1):41-9. PubMed ID: 15370366
[TBL] [Abstract][Full Text] [Related]
20. Vision-related quality-of-life assessment using NEI VFQ-25 in patients after Boston keratoprosthesis implantation.
Cortina MS; Hallak JA
Cornea; 2015 Feb; 34(2):160-4. PubMed ID: 25411934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
